NZ512476A - Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma - Google Patents

Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Info

Publication number
NZ512476A
NZ512476A NZ512476A NZ51247699A NZ512476A NZ 512476 A NZ512476 A NZ 512476A NZ 512476 A NZ512476 A NZ 512476A NZ 51247699 A NZ51247699 A NZ 51247699A NZ 512476 A NZ512476 A NZ 512476A
Authority
NZ
New Zealand
Prior art keywords
triazineone
toltrazuril
compound
neospora
ponazuril
Prior art date
Application number
NZ512476A
Other languages
English (en)
Inventor
Thomas J Kennedy
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NZ512476A publication Critical patent/NZ512476A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ512476A 1998-12-22 1999-12-17 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma NZ512476A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21871298A 1998-12-22 1998-12-22
PCT/US1999/030284 WO2000037084A1 (en) 1998-12-22 1999-12-17 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Publications (1)

Publication Number Publication Date
NZ512476A true NZ512476A (en) 2003-08-29

Family

ID=22816194

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ512476A NZ512476A (en) 1998-12-22 1999-12-17 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Country Status (12)

Country Link
EP (1) EP1140101A1 (ko)
JP (1) JP2002532552A (ko)
KR (1) KR20010080571A (ko)
CN (1) CN1331595A (ko)
AU (1) AU2198100A (ko)
BR (1) BR9916417A (ko)
CA (1) CA2356181A1 (ko)
HK (1) HK1043065A1 (ko)
HU (1) HUP0104716A3 (ko)
NZ (1) NZ512476A (ko)
WO (1) WO2000037084A1 (ko)
ZA (1) ZA200103919B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9914385A (pt) 1998-10-08 2001-07-17 New Ace Res Company Composição útil para o tratamento e prevenção de infecções protozoárias no homem e em animais, e, método de tratamento de uma infecção protozoária no homem e em animais
DE19958388A1 (de) * 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
DE10040174A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10040110A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
DE102007025908A1 (de) * 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
CN102973497A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种托曲珠利溶液及其制备方法
JP7350759B2 (ja) 2018-02-26 2023-09-26 アルゼキュア ファーマ アーべー ニューロトロフィンに関連する疾患を治療するためのトリアジン誘導体
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998043644A1 (en) * 1997-03-31 1998-10-08 David Granstrom Formulations and methods to treat and prevent equine protozoal myeloencephalitis

Also Published As

Publication number Publication date
HUP0104716A2 (hu) 2002-04-29
WO2000037084A1 (en) 2000-06-29
HK1043065A1 (zh) 2002-09-06
EP1140101A1 (en) 2001-10-10
CN1331595A (zh) 2002-01-16
CA2356181A1 (en) 2000-06-29
ZA200103919B (en) 2002-05-15
AU2198100A (en) 2000-07-12
HUP0104716A3 (en) 2003-10-28
KR20010080571A (ko) 2001-08-22
JP2002532552A (ja) 2002-10-02
BR9916417A (pt) 2001-11-06

Similar Documents

Publication Publication Date Title
AU770108B2 (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
NZ512476A (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
US6150361A (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
US6429211B1 (en) Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
MXPA01006436A (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
MXPA01006435A (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
MXPA01006437A (en) Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed